论文部分内容阅读
目的:观察低分子肝素钠联合血塞通治疗急性脑梗死的疗效。方法:116例急性脑梗死患者随机分为治疗组和对照组各58例,两组均常规治疗,包括脱水降低颅内压、减轻脑水肿、神经保护剂、阿司匹林、维持水电解质平衡及全身营养治疗。治疗组在此基础上加用低分子肝素钠5 000 U脐周sc,1次/d;血塞通0.4 g+5%葡萄糖(0.9%生理盐水)250 mL中静脉点滴,1次/d;14 d为1个疗程。观察两组患者治疗前后神经功能缺损评分,临床疗效及血液流变学指标的变化。结果:治疗组总有效率及治疗前后血液流变学指标变化与对照组比较差异显著(P<0.05),治疗组神经功能缺损评分与对照组比较差异显著(P<0.01)。结论:低分子肝素钠联合血塞通治疗急性脑梗死有较好的疗效,无明显不良反应。
Objective: To observe the effect of low molecular weight heparin combined with Xuesaitong on acute cerebral infarction. Methods: A total of 116 patients with acute cerebral infarction were randomly divided into treatment group (58 cases) and control group (58 cases). Both groups received routine treatment including dehydration to reduce intracranial pressure, cerebral edema, neuroprotective agents, aspirin, water and electrolyte balance and body nutrition treatment. On the basis of this, the treatment group was treated with low-molecular-weight heparin sodium for 5 000 U umbilical week, once / d; Xuesaitong 0.4 g + 5% glucose (0.9% saline) 14 d for a course of treatment. The changes of neurological deficit score, clinical curative effect and hemorheology indexes before and after treatment were observed in both groups. Results: The total effective rate of the treatment group and the changes of hemorrheological indexes before and after treatment were significantly different from those of the control group (P <0.05). The neurological deficit score of the treatment group was significantly different from that of the control group (P <0.01). Conclusion: Low molecular weight heparin combined with Xuesaitong treatment of acute cerebral infarction has a good effect, no obvious adverse reactions.